Prof. Wasim Hanif is a Professor of Diabetes & Endocrinology & Consultant Physician, Clinical Director in diabetes at University Hospital Birmingham.
He is an eminent authority on Diabetes, Obesity, and Ethnic health. He works with several national bodies, and professional groups in the UK.
Prof. Hanif received his specialist training in Birmingham and has worked at major teaching centres in the city. He received an MD for research in South Asians with diabetes from University of Birmingham. He has been involved with major research projects in diabetes and has published widely. He was selected for Kings Fund Leadership Programme in Diabetes. His research interest includes: diabetic kidney disease, diabetes prevention, management of diabetes in Ramadan, obesity, ethnicity and tackling health inequalities.
He is involved as a chief and principal investigator in several international multi-centre trials and was instrumental in setting up UKADS (United Kingdom Asian Diabetes Study).
Prof. Hanif has been involved at a parliamentary level to advise the government on issues relating to Diabetes and ethnic health. He is the Chair of the Diabetes Working Group of the South Asian Heart Foundation (SAHF) a world recognised organisation on South Asian Health. Prof. Hanif is a member of the Parliamentary and Stakeholder Diabetes Think Tank advising the All Party Parliamentary Group on Diabetes. He is also a member of the Parliamentary Best Practice Consensus Group on Diabetes in South Asians. He is on the Board of Directors for Apnee Sehat a social enterprise for innovative Healthcare delivery in the UK.
Prof. Hanif has authored several publications, toolkits and guides in ethnic health. In 2009, he produced and authored a report on the gaps in research among South Asians with Diabetes in the UK that was launched at the Houses of Parliament on the 17th June 09 by Lord Naren Patel and Right Hon Keith Vaz MP.
His involvement in NICE has been extensive, sitting on advisory NICE Health Technology Appraisal Committees, and acting as an advisor on many issues including the use of health technologies, definitions of Obesity and Waist circumference in British South Asians, prevention of diabetes in high risk groups, physical activity, type 2 diabetes, and new agents for treatment of type 2 diabetes and Rimonobant STA.